Llwytho...
Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis
CONTEXT: Kang-ai injection (KAI) is an authorized herbal medicine used in cancer treatment. However, its clinical efficacy in hepatocellular carcinoma (HCC) has not been investigated thoroughly. OBJECTIVE: To systematically evaluate the efficacy and safety of KAI in patients with HCC. MATERIALS AND...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharm Biol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8081330/ https://ncbi.nlm.nih.gov/pubmed/33905666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2021.1915340 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|